Up Next
Back to Show
PBS News Hour
FDA criticized for Alzheimer's drug approval process
New findings from a congressional investigation into the Food and Drug Administration and the biotech company Biogen find the FDA broke its own protocols to approve a new Alzheimer’s drug last year. The report said the FDA worked too closely with Biogen despite significant concerns over the limited benefits and side effects of the new drug, Aduhelm. Geoff Bennett reports.
Sign up now for inspiring and thought-provoking media delivered straight to your inbox.
Support Provided By
56:34
May 30, 2025 - PBS News Hour full episode
57:46
May 29, 2025 - PBS News Hour full episode
57:46
May 28, 2025 - PBS News Hour full episode
57:46
May 27, 2025 - PBS News Hour full episode
57:46
May 26, 2025 - PBS News Hour full episode
26:45
May 25, 2025 - PBS News Weekend full episode
26:45
May 24, 2025 - PBS News Weekend full episode
57:46
May 23, 2025 - PBS News Hour full episode
57:46
May 22, 2025 - PBS News Hour full episode
57:46
May 21, 2025 - PBS News Hour full episode
57:46
May 20, 2025 - PBS News Hour full episode
57:46
May 19, 2025 - PBS News Hour full episode